The N-myc-amplified neuroblastoma cell lines UKF-NB-2, UKF-NB-3, and UKF-NB-6 were established from stage 4 neuroblastoma patients.31 (link), 32 (link), 33 (link) The alveolar rhabdomyosarcoma cell line UKF-Rhb-1 was established from a bone marrow metastasis.11 (link) The melanoma cell lines Colo-679 and Mel-HO were obtained from the DSMZ (Braunschweig, Germany).
Parental chemosensitive cell lines were adapted to growth in the presence of anti-cancer drugs by continuous exposure of these cell lines to the increasing concentrations of these drugs as described before.31 (link), 32 (link)The following chemoresistant UKF-NB-3 sublines were derived from the resistant cancer cell line (RCCL) collection: UKF-NB-3rCDDP1000 (adapted to CDDP), UKF-NB-3rDAC8 (DAC), UKF-NB-3rDOX20 (DOX), UKF-NB-3rGEMCI10 (GEMCI), UKF-NB-3rIRINO800 (IRINO), UKF-NB-3rMEL400 (MEL), UKF-NB-3rOXALI2000 (OXALI), UKF-NB-3rPCL20 (PCL), UKF-NB-3rTOPO15 (TOPO), UKF-NB-3rVCR10 (VCR), and UKF-NB-3rVINOR20 (VINOR).
The following chemoresistant UKF-NB-2 sublines were derived from the RCCL collection: UKF-NB-2rCDDP1000, UKF-NB-2rDOX20, and UKF-NB-2rVCR10.
The following chemoresistant UKF-Rhb-1 sublines were derived from the RCCL collection: UKF-Rhb-1rCDDP1000 and UKF-Rhb-1rDOCE10 (DOCE), UKF-Rhb-1rDOX10, UKF-Rhb-1rGEMCI10, UKF-Rhb-1rIRINO200, UKF-Rhb-1rMEL400, UKF-Rhb-1rOXALI1000, and UKF-Rhb-1rVCR10Moreover, the following melanoma sub-lines were derived from the RCCL collection: Colo-679rVCR20, Colo-679rPLX403210 μM (PLX4032, vemurafenib), MelHOrVCR20, MelHOrCDDP1000, MelHOrDAC20, and MelHOrPLX403210 μM.
The corresponding IC50 values for the parental cells and their drug-resistant sublines are provided inSupplementary Table 4 .
All cells were propagated in IMDM supplemented with 10% FBS, 100 IU/ml penicillin and 100 mg/ml streptomycin at 37 °C. Cells were routinely tested for mycoplasma contamination and authenticated by short tandem repeat profiling.
Standard molecular cloning techniques were used to generate lentiviral vectors based on Lentiviral Gene Ontology vector technology (seehttp://www.lentigo-vectors.de ), and cell transduction was performed as described before.11 (link), 18 (link), 34 (link)
Parental chemosensitive cell lines were adapted to growth in the presence of anti-cancer drugs by continuous exposure of these cell lines to the increasing concentrations of these drugs as described before.31 (link), 32 (link)The following chemoresistant UKF-NB-3 sublines were derived from the resistant cancer cell line (RCCL) collection: UKF-NB-3rCDDP1000 (adapted to CDDP), UKF-NB-3rDAC8 (DAC), UKF-NB-3rDOX20 (DOX), UKF-NB-3rGEMCI10 (GEMCI), UKF-NB-3rIRINO800 (IRINO), UKF-NB-3rMEL400 (MEL), UKF-NB-3rOXALI2000 (OXALI), UKF-NB-3rPCL20 (PCL), UKF-NB-3rTOPO15 (TOPO), UKF-NB-3rVCR10 (VCR), and UKF-NB-3rVINOR20 (VINOR).
The following chemoresistant UKF-NB-2 sublines were derived from the RCCL collection: UKF-NB-2rCDDP1000, UKF-NB-2rDOX20, and UKF-NB-2rVCR10.
The following chemoresistant UKF-Rhb-1 sublines were derived from the RCCL collection: UKF-Rhb-1rCDDP1000 and UKF-Rhb-1rDOCE10 (DOCE), UKF-Rhb-1rDOX10, UKF-Rhb-1rGEMCI10, UKF-Rhb-1rIRINO200, UKF-Rhb-1rMEL400, UKF-Rhb-1rOXALI1000, and UKF-Rhb-1rVCR10Moreover, the following melanoma sub-lines were derived from the RCCL collection: Colo-679rVCR20, Colo-679rPLX403210 μM (PLX4032, vemurafenib), MelHOrVCR20, MelHOrCDDP1000, MelHOrDAC20, and MelHOrPLX403210 μM.
The corresponding IC50 values for the parental cells and their drug-resistant sublines are provided in
All cells were propagated in IMDM supplemented with 10% FBS, 100 IU/ml penicillin and 100 mg/ml streptomycin at 37 °C. Cells were routinely tested for mycoplasma contamination and authenticated by short tandem repeat profiling.
Standard molecular cloning techniques were used to generate lentiviral vectors based on Lentiviral Gene Ontology vector technology (see